Design: Systematic review and meta-analysis of 17 observational studies
Population: 18,043 people screened by whole-body MRI without an evidence-based indication
Primary outcome: Proportion with findings, actionable findings, and new cancer diagnoses
Effect: 78% any finding; 14.8% actionable non-malignant; malignancy 1.4%; outcomes undetermined

A meta-analysis pooled 18,043 people who had whole-body MRI as a screen, with no evidence-based indication for it, across 17 heterogeneous and generally low-quality studies.

Most scans generated work rather than answers. Some 78% had a finding reported; about 15% had an actionable non-malignant finding, of whom most went on to further laboratory tests or imaging and one in five to a procedure. Cancer was found in 1.4%. Crucially, whether finding any of this changed outcomes could not be determined.

For the physician asked about commercially marketed full-body scans — common in Indian corporate and private health checks — this is the counselling point: the likeliest result is an incidental finding that triggers more tests and anxiety, with no shown benefit. The evidence to recommend it simply is not there.

About four in five whole-body screening MRIs reported a finding; most needed no action.
Roughly 15% produced an actionable non-malignant finding, usually leading to more tests.
Cancer was detected in 1.4%, and no study showed the scans improved outcomes.
Counsel patients requesting full-body scans about the high chance of a workup-triggering incidental finding.

Why it matters

It gives the clinician evidence to push back on a heavily marketed test that generates downstream work without shown benefit.

The statistics, in plain English

The pooled estimates come from low-quality studies with very wide confidence intervals, so the exact percentages are soft — but the direction is clear and the one thing missing, a link to better outcomes, is the thing that would justify the test.